Latest Updates

Better Blood Transfusion TOOLKIT

February 2013

Pre Op Assessment for Jehovah's Witnesses section has been updated, including a revised version of the blood conservation care plan for Jehovah's Witness patients with malignant disease.

January 2013

Blood Transfusion in 'out of acute hospital' settings - an updated version of this document framework is now available.

February 2012

E-learning facilities - an updated summary of all LearnBloodTransfusion modules available, including Learn Cell Salvage.

January 2012

Clinical Audit – ‘What is Clinical Audit’ section updated.

December 2011

SaBTO Consent for Blood Transfusion - A summary of the recommendations from the Advisory Committee on the Safety of Blood, Tissues and Organs (SaBTO) related to consent for blood transfusion, and links to the various resources which have been produced as a result of the consultation process.

2011

UK Cell Salvage Action Group – full update of information and resources available.

Go to the top of this page

Document Library updates

A new page with papers supporting the Change Notifications has been created.

August 2014

Publication of Change Notifications No 29 - 40 2014

Publication of Change Notifications No 41 - 2014

July 2014

Publication of Change Notification No 27 and 28 2014

June 2014

Publication of Change Notifications No. 18- 26

Publication of supporting paper Interstitial Cystitis (IC) or Painful Bladder Syndrome

April 2014

The JPAC Position Statement on The estimated risk that a donation entering the blood supply is a potentially infectious window period donation: risks specific for HBV, HCV and HIV in the UK, 2010 - 2012 has been updated

February 2014

Publication of Change Notification No 18, 20, 21 and 22 - 2013

Change Notification 19-2013 Not published

Publication of supporting paper Carcinoma in situ

Publication of supporting paper Tamoxifen or Raloxifen for breast cancer prevention

Publication of Change Notification 01 - 2014

The JPAC Position Statement on Granulocyte Therapy has been updated

January 2014

Publication of Change Notification 15-17 - 2013

Publication of supporting paper Shelf-life (when frozen) of FFP, cryoprecipitate, cryodepleted plasma and MB-treated FFP

September 2013

Publication of Change Notification 13-14 - 2013

July 2013

Publication of Change Notification 02-07 - 2013

Publication of Change Notification 08-10 - 2013

June 2013

The JPAC paper on Deviations from the specified storage temperature for Fresh-Frozen Plasma (FFP) whilst in its frozen state has been updated 'General Documents'

The JPAC Position Statement on Chikungunya Virus has been updated

Publication of Change Notification 11-12 - 2013

May 2013

Publication of Change Notification 01 - 2013

February 2013

Publication of Change Notification 27-29 - 2012

Publication of supporting paper Sickle Cell Trait and Apheresis

Publication of supporting paper Decompression illness

The JPAC paper on Shelf-life of Frozen Plasma Components Following Thawing has been added to 'General Documents'

December 2012

The JPAC Position Statement on Methylene Blue-Treated Plasma has been added

The JPAC Position Statement on Blood donor selection to minimise risk of transfusion transmissible infectious agents entering the blood supply has been updated

November 2012

The JPAC Position Statement on Creutzfeldt-Jakob Disease has been updated

The JPAC Position Statement on Granulocyte Therapy has been updated

The JPAC Position Statement on The estimated risk that a donation entering the blood supply is a potentially infectious window period donation: risks specific for HBV, HCV and HIV in the UK, 2010 - 2011 has been updated

October 2012

The JPAC Position Statement on Creutzfeldt-Jakob Disease has been updated

Publication of Change Notification 20-24 - 2012

Publication of Change Notification 25 - 2012

Publication of Change Notification 26 - 2012

August 2012

Publication of Change Notification 19 - 2012

June 2012

The JPAC Position Statement on Emerging Infections has been updated

Publication of Change Notification 06-18 - 2012

Publication of supporting paper Recommendations on a change to the Donor Selection Guidance for Pregnancy

Publication of supporting paper Toxoplasmosis DSG entry

May 2012

The JPAC Position Statement on The estimated risk of HBV, HCV and HIV potentially infectious donations entering the UK blood supply due to the window period of tests in use, 2008 – 2010 has been updated

April 2012

The JPAC paper on Validation of Blood Component Quality Following Prion Removal Procedures for Red Cell Components has been updated 'General Documents'.

The JPAC paper on Evaluation of novel platelet components has been removed from 'General Documents'

The JPAC Position Statement on Chikungunya Virus has been updated

The JPAC paper on Evaluation of Efficacy of Prion Removal Filters has been updated 'General Documents'

March 2012

Publication of Change Notification 03-05 - 2012

The JPAC Position Statement on Cytomegalovirus (CMV) has been withdrawn following the publication of the Government’s Advisory Committee on the Safety of Blood, Tissues and Organs (SaBTO) Position Statement on CMV

The JPAC Position Statement on West Nile Virus (WNV) has been updated

February 2012

Publication of Change Notification 01-02 - 2012

January 2012

Publication of Change Notification 22 -27 - 2011

Publication of supporting paper Recommendations on Donor Height and Weight

December 2011

Publication of Change Notification 20 - 2011

Publication of Change Notification 21 - 2011

Publication of supporting paper Risk assessment for immunosuppression and corneal donation

November 2011

Publication of Change Notification 16 - 2011

Publication of Change Notification 17 - 2011

Publication of Change Notification 19 - 2011

The Blood Safety Leaflet Information -

this version has been updated and contains information which applies to England, Scotland and Wales only

The Blood Safety Leaflet Information -

this version applies to Northern Ireland Only

The JPAC Position Statement on 2011 Blood donor selection to minimise risk of transfusion transmissible infectious agents entering the blood supply has been added

October 2011

The JPAC paper on Deviations from the specified storage temperature for Fresh-Frozen Plasma (FFP) whilst in its frozen state has been added to 'General Documents'

Publication of Change Notification 18 - 2011

The JPAC Position Statement on West Nile Virus (WNV) has been updated

September 2011

Publication of Change Notification 14 - 2011

Publication of supporting paper Recommendation for a change to the Live Tissue Donor Selection guidance for Malaria

August 2011

Publication of Change Notification 11 - 2011

Publication of Change Notification 12 - 2011

Publication of Change Notification 13 - 2011

Publication of Change Notification 15 - 2011

July 2011

The JPAC paper on List of Evaluations has been updated 'General Documents'.

The JPAC Position Statement on Emerging Infections has been added.

June 2011

Publication of Change Notification 1 - 5 - 2011

Publication of Change Notification 6 - 9 - 2011

March 2011

The JPAC Position Statement on CMV Seronegative vs. Leucodepleted blood components for at risk recipients has been updated

February 2011

Publication of Change Notification 12 - 2010

Publication of Change Notification 13 - 2010

The JPAC Position Statement on Chikungunya Virus has been updated

January 2011

Amendment to Change Notification No.7 - 2010

Publication of Change Notification 14 - 2010

December 2010

The JPAC Position Statement on Granulocyte Therapy has been updated

November 2010

Publication of Change Notification 11 - 2010

Publication of supporting paper Long term storage of tissue products v1

Publication of Change Notification 8 - 2010

Publication of Change Notification 7 - 2010

September 2010

The JPAC Position Statement on Estimated infection risk - Blood has been added

Publication of Change Notification 9 & 10 - 2010

The JPAC Position Statement on Creutzfeldt-Jakob Disease has been updated

Diary of Educational Events has been updated.

Publication of Change Notification 6 - 2010

Publication of supporting paper Addition to 14.5.1 of the Red Book to allow rare antisera to be used in investigations.

April 2010

The JPAC Position Statement on Creutzfeldt-Jakob Disease has been updated

March 2010

The JPAC Position Statement on West Nile Virus (WNV) has been updated

The JPAC Position Statement on Blood donor selection has been updated

Publication of Change Notification 2 - 5 - 2010

January 2010

The JPAC paper on 'Deviations from 4 oC temperature storage for red cells: Effect on viability and bacterial growth' is now available as a PDF download from the library page 'General Documents'.

The JPAC paper on 'Validation of Blood Component Quality Following Prion Removal Procedures for Red Cell Components' has been updated 'General Documents'.

Position statement Severe Acute Respiratory Syndrome (SARS) reconfirmed.

Publication of Change Notification 1 - 2010

Publication of supporting paper HbS testing neonatal red cell components

December 2009

Publication of Change Notification 28 - 31 - 2009

Publication of Change Notification 32 - 35 - 2009

November 2009

Commission Directive 2009/135/EC added to EU Directives & Regulations

Publication of Position Statement Chikungunya Virus

Publication of Position Statement Granulocyte Therapy

October 2009

Publication of Change Notification 27 - 2009

Publication of Change Notification 23 - 2009

Publication of Proposal to amend the content of 12.1.4 f) of the 2005 Guidelines.

The JPAC paper on 'The Use of G-CSF in Unrelated Volunteer Stem Cell Donors ' is now available as a PDF download from the library page 'General Documents' has been added.

September 2009

Publication of Change Notification 24 - 26 - 2009

August 2009

Publication of Change Notification 18 - 22 - 2009

July 2009

Publication of Change Notification 17 - 2009

Publication of Change Notification 16 - 2009

June 2009

Publication of Change Notification 12 - 2009

May 2009

Publication of Position Statement Creutzfeldt-Jakob Disease

Publication of Change Notification 8 to 10 & 13 to 15 - 2009

April 2009

Publication of Change Notification 11 - 2009

Pandemic Influenza - The UK Blood Services Plan has been updated.

February 2009

Publication of Change Notifications 03 to 07 - 2009

January 2009

The JPAC Position Statement on Granulocyte Therapy has been updated.

Publication of Change Notifications 01 & 02 - 2009

December 2008

The JPAC paper on 'Recommendations for removal of the upper age limit for regular whole blood and component donors' is now available as a PDF download from the library page 'General Documents' has been updated.

November 2008

The Summary and Report of the JPAC workshop on management of haemoglobin and iron in blood donors are available on this website.

Go to the top of this page

 

 

Guidelines for the Blood Services in the UK

January 2014

Change Notification No.15 - 2013

Change Notification No.16 - 2013

Errata - Amended pages

  • Section 7.9.1 - Platelets, Pooled, Buffy Coat Derived, Leucocyte Depleted
  • Section 7.11.1 - Platelets in Additive Solution and Plasma, Leucocyte Depleted
  • Section 9.5.3.1 - Single-test system
  • Section 12.11.2 - Blood and blood components from group O donors with high titres of anti-A, anti-B and/or anti-A,B
  • Section7.12.1 - Platelets in Additive Solution, Leucocyte Depleted

Change Notification No.17 - 2013

Shelf-life (when frozen) of FFP, cryoprecipitate, cryodepleted plasma and MB-treated FFP

  • Section 7.15 - Fresh Frozen Plasma, Leucocyte Depleted
  • Section 7.16 - Fresh Frozen Plasma, Methylene Blue Treated and Removed, Leucocyte Depleted
  • Section 7.17 - Cryoprecipitate, Leucocyte Depleted
  • Section 7.18 - Cryoprecipitate Pooled, Leucocyte Depleted
  • Section 7.20 - Plasma, Cryoprecipitate Depleted, Leucocyte Depleted
  • Section 7.27 - Fresh Frozen Plasma, Neonatal Use, Methylene Blue Treated and Removed, Leucocyte Depleted
  • Section 7.28 - Cryoprecipitate, Methylene Blue Treated and Removed, Leucocyte Depleted
  • Section 7.33 - Cryoprecipitate, Pooled, Methylene Blue Treated and Removed, Leucocyte Depleted

June 2013

Change Notification No.11 - 2013

Section 7.33 - Cryoprecipitate, Pooled, Methylene Blue Treated and Removed, Leucocyte Depleted

Change Notification No.12 - 2013

Annex 3 - Platelets in Additive Solution and Plasma, Leucocyte Depleted, Pathogen-reduced

Go to the top of this page

 

 

Geographical Disease Risk Index

This page lists all changes to GDRI 001 after Release 01.
The changes are listed with the most recent change at the top.

Changes made with Release 22
Changes made to

British Virgin Islands
Anguilla
Saint Martin
Sint Maarten
Saint Bathelemy
Former Netherlands Antilles
Antigua and Barbuda
St Kitts and Nevis
Montserrat
Guadeloupe
Dominica
Martinique see Change Notification No. 01 - 2014

Changes made with Release 21 Issue 02
The topic Virgin Islands and appendix1 have been removed and updates to information in the Welcome page and Preliminaries pages – Introduction, Document and Change Control have been made

Changes made with Release 21
Changes made to Austria, Bosnia and Herzegovina, Bulgaria, Montenegro and Russia see Change Notification No. 14 - 2013

Changes made with Release 20
Chikungunya Virus Risk See Change Notification No. 04 - 2013
A new topic for South Sudan has been added
Changes have been made to a number of topics for Chikungunya risk

East Timor topic title has been changed to Timor
Congo (Democratic Republic of - Kinshasa) topic title has been changed to Congo
Index names have been updated for links to Congo and Timor
Netherlands Antilles topic title changed to Former Netherlands Antilles
Virgin Islands topic removed
Additional Antilles Islands added with links to relevant topics.

Changes made with Release 19
Changes made to
Hungary, Croatia and Kosovo See Change Notification No. 25 - 2012
Changes made to
Algeria See Change Notification No. 26 - 2012

Changes made with Release 18
Changes made to
Iran, Iraq and Vietnam see Change Notification No. 20 - 2012
Changes made to
United States of America see Change Notification No. 21 - 2012
Search facility updated

Changes made with Release 17
Changes made to
West Bank, Gaza Strip, Tunisia, Greece, Serbia and Russia
see Change Notification No. 19 - 2012
Index items for West Bank, Gaza Strip and Palestine Occupied Territories, Palestine Occupied Territories and Transjordan added.

Changes made with Release 16
Changes made to
Cambodia, Columbia, Ecuador, Egypt, Ethiopia, Guatemala, India, Indonesia, Jamaica, Kenya, Laos, Namibia, Nicaragua, Suriname, Swaziland, Syria, Thailand, Vietnam and Zimbabwe
see Change Notification No. 14 - 2012
Index items for Sicily, Corsica and Koh Samui added.

Changes made with Release 15
Changes made to
Albania, Canada, Greece, Israel, Italy, Macedonia (FYR), Romania, Russia, Saint Pierre and Miquelon, Turkey and USA. see Change Notification No. 04 - 2012

Changes made with Release 14 Issue 02
Malaria Risk updated for Morocco, Mauritius, Costa Rica, Peru, Panama, Sri Lanka, United Arab Emirates
Spelling of Malaria corrected on all Malaria Risk Category Subheadings.
Preliminaries Introduction page contact information has been updated.

Changes made with Release 14
Changes made to
Italy see Change Notification No. 19 - 2011

Changes made with Release 13
Changes made to
Macedonia, Russia and Turkey see Change Notification No. 18 - 2011

Changes made with Release 12
Changes made to
Albania, Israel and Russia see Change Notification No. 15 - 2011

Changes made with Release 11
Changes made to
Romania see Change Notification No. 12 - 2011
Greece see Change Notification No. 13 - 2011

Changes made with Release 10
Changes made to
see Change Notification No. 10 - 2010

Changes made with Release 09
Changes made to
Maldives see Change Notification No. 27 - 2009

Changes made with Release 08
Changes made to
Italy see Change Notification No. 25 - 2009
Canada, United States of America see Change Notification No. 26 - 2009

Changes made with Release 07
Changes made to
Italy see Change Notification No. 11 - 2009
This reverses the changes made with Change Notification No. 05 - 2007.

Changes made with Release 06
This release is the first implementation of the GDRI on the website. Layout and ordering of entries may differ on the website as compared to the Portable Document File (PDF) but there are no changes to the wording of any entries. Consequently no new PDF file is released.

Changes made with Release 05
Errata corrections made to
Italy see Change Notification No. 05 - 2007
Jamaica see Change Notification No. 20 - 2006

Changes made with Release 04
Introduction – Malaria: Airport stopovers see Change Notification No. 15 - 2007

Changes made with Release 03
Bahamas (The) see Change Notification No. 07 - 2007
Canada see Change Notification No. 08 - 2007
United States of America see Change Notification No. 08 - 2007

Changes made with Release 02
Egypt see Change Notification No. 02 - 2007
Ethiopia see Change Notification No. 02 - 2007

Go to the top of this page

 

 

Whole Blood and Components

This page lists all changes to DSG-WB 203 after Release 01.
This pages constitutes Section 2 of Appendix 1 - Changes to the Donor Selection Guidelines.
The changes are listed with the most recent change at the top.

Changes introduced with Release 19
West Nile Virus (WNV) See Change Notification No. 14 - 2013

Changes introduced with Release 18
Hepatitis B See Change Notification No. 02 - 2013
Infection Chronic See Change Notification No. 03 - 2013
Chest Pain See Change Notification No. 05 - 2013
Cardiovascular Disease See Change Notification No. 06 - 2013
Wounds, Mouth and Skin Ulcers See Change Notification No. 07 - 2013

Changes introduced with Release 17
West Nile Virus (WNV) See Change Notification No. 01 - 2013

Changes introduced with Release 16
Sickle-Cell Trait See Change Notification No. 27 - 2012
Kidney Disease See Change Notification No. 28 - 2012
Decompression Illness See Change Notification No. 29 - 2012
Index items for Decompression Illness, Decompression Sickness, the Bends and Caisson Disease have been added.

Changes introduced with Release 15
West Nile Virus (WNV) See Change Notification No. 25 - 2012
West Nile Virus (WNV) See Change Notification No. 26 - 2012

Changes introduced with Release 14
Malaria See Change Notification No. 20 - 2012
West Nile Virus See Change Notification No. 21 - 2012
Cupping/Wet Cupping See Change Notification No. 22 - 2012
Cardiovascular Disease See Change Notification No. 23 - 2012
Mobilised Granulocytes See Change Notification No. 24 - 2012
Index items for Cupping, Wet Cupping, Heart Murmur and Heart Valve Abnormality have been added

Changes introduced with Release 13
West Nile Virus (WNV) See Change Notification No. 19 - 2012

Changes introduced with Release 12
Acne See Change Notification No. 06 - 2012
Toxoplasmosis See Change Notification No. 07 - 2012
Psoriasis See Change Notification No. 08 - 2012
Pregnancy See Change Notification No. 09 - 2012
Dermatitis See Change Notification No. 10 - 2012
Skin Disease See Change Notification No. 11 - 2012
Cardiovascular Disease See Change Notification No. 12 - 2012
Cardiac Surgery See Change Notification No. 13 - 2012

Clarification has been made to the malignancy topic and additional index items for Fish pedicures, Lichen Planus, Acitretin - for Skin Disease, Neotigason - for Skin Disease, Tacrolimus - for Dermatitis, Tacrolimus - for Skin Disease, Protopic - for Dermatitis, Protopic - for Skin Disease, Pimecrolimus - for Dermatitis, Pimecrolimus - for Skin disease, Elide - for Dermatitis, Elide - for Skin Disease added.

Changes introduced with Release 11
West Nile Virus (WNV) See Change Notification No. 03 - 2012

Changes introduced with Release 10
Donor Weight See Change Notification No. 22 - 2011
Cardiovascular Disease See Change Notification No. 23 - 2011
Surgery See Change Notification No. 24 - 2011
XMRV See Change Notification No. 25 - 2011
Hepatitis C See Change Notification No. 26 - 2011

Changes introduced with Release 09
Blood Safety Entry See Change Notification No. 16 - 2011
Homosexual and Bisexual Individuals See Change Notification No. 17 - 2011
West Nile Virus (WNV) See Change Notification No. 19 - 2011

Changes introduced with Release 08
West Nile Virus (WNV) See Change Notification No. 18 - 2011

Changes introduced with Release 07
West Nile Virus (WNV) See Change Notification No. 15 - 2011

Changes introduced with Release 06
West Nile Virus (WNV) See Change Notification No. 11 - 2011

Changes introduced with Release 05
Pregnancy See Change Notification No. 01 - 2011
Trying to Conceive See Change Notification No. 02 - 2011
Immunization - Live See Change Notification No. 03 - 2011
Syphilis See Change Notification No. 04 - 2011
Porphyria See Change Notification No. 05 - 2011

Changes introduced with Release 04
Donor Weight and Donation Volumes See Change Notification No. 13 - 2010

Changes introduced with Release 03
Chronic Fatigue Syndrome See Change Notification No. 08 - 2010

Changes introduced with Release 02
West Nile Virus (WNV) See Change Notification No. 09 - 2010

Go to the top of this page

 

 

Bone Marrow and Peripheral Blood Stem Cell

This page lists all changes to TDSG-BM 203 after Release 02.
This pages constitutes Section 2 of Appendix 1 - Changes to the Donor Selection Guidelines.

Changes introduced with Release 03
A change was made to the version control definitions and all Issue numbering information removed.
Bleeding Disorder See Change Notification No. 18 - 2007

Changes introduced with Release 04
Blood Pressure - High See Change Notification No. 1 - 2008
Appendix 4 removed See Change Notification No. 5 – 2008
This update also corrects an error where commas did not display in the A-Z topics content on the website.

Changes introduced with Release 05
Tamiflu® (oseltamivir) See Change Notification No. 30 - 2009
Relenza® (zanamivir) See Change Notification No. 31 - 2009

Changes introduced with Release 06
Acupuncture See Change Notification No. 33 - 2009
Complementary Therapy See Change Notification No. 35 - 2009

Changes introduced with Release 07
Body Piercing See Change Notification No. 02 - 2010
Inoculation Injury See Change Notification No. 04 - 2010
Endoscopy See Change Notification No. 05 - 2010

Changes introduced with Release 08
West Nile Virus (WNV) See Change Notification No. 09 - 2010

Changes introduced with Release 09
Immunization - Live See Change Notification No. 06 - 2011
BCG See Change Notification No. 07 - 2011
Infertility See Change Notification No. 08 - 2011
Sexually Transmitted Disease See Change Notification No. 09 - 2011

Changes introduced with Release 10
West Nile Virus (WNV)See Change Notification No. 11 - 2011

Changes introduced with Release 11
Porphyria See Change Notification No. 20 - 2011

Changes introduced with Release 12
XMRV See Change Notification No. 25 - 2011
Hepatitis C See Change Notification No. 27 - 2011

Changes introduced with Release 13
West Nile Virus (WNV) See Change Notification No. 05 - 2012

Changes introduced with Release 14
Acne See Change Notification No. 15 - 2012
Pregnancy See Change Notification No. 16 - 2012
Psoriasis See Change Notification No. 17 - 2012
Toxoplasmosis See Change Notification No. 18 - 2012

Changes introduced with Release 15
West Nile Virus (WNV) See Change Notification No. 01 - 2013

Changes introduced with Release 16
Hepatitis B See Change Notification No. 08 - 2013
Hepatitis B Post Immunization See Change Notification No. 09 - 2013
Infection - Chronic See Change Notification No. 10 - 2013

Changes introduced with Release 17
Acupuncture See Change Notification No. 02 - 2014
Alitretinoin, Toctino, Acne and Dermatitis See Change Notification No. 03 - 2014
Body Piercing See Change Notification No. 04 - 2014
Central Nervous System Disease See Change Notification No. 05 - 2014
Hepatitis B - Post Immunization See Change Notification No. 06 - 2014
Hepatitis B See Change Notification No. 07 - 2014
Hepatitis of Unknown Origin See Change Notification No. 08 - 2014
Kidney Disease See Change Notification No. 10 - 2014
Malignancy See Change Notification No. 11 - 2014
Mental Health Problems See Change Notification No. 12 - 2014
Sarcoidosis See Change Notification No. 13 - 2014
South American Trypanosomiasis Risk See Change Notification No. 14 - 2014
Paratyphoid and Typhoid See Change Notification No. 15 - 2014
Weight See Change Notification No. 16 - 2014

Changes introduced with Release 18
Change of Title See Change Notification No. 29 - 2014
Haematological Disease See Change Notification No. 30 - 2014
SARS See Change Notification No. 31 - 2014
Tissues Safety See Change Notification No. 32 - 2014
Homosexual and Bisexual Individuals See Change Notification No.34 - 2014
Sex Change See Change Notification No.38 - 2014

Go to the top of this page

 

Cord Blood

This page lists all changes to TDSG-CB 203 after Release 02. This page constitutes Section 2 of Appendix 1 - Changes to the Donor Selection Guidelines.
The changes are listed with the most recent change at the top.

Changes introduced with Release 03
A change was made to the version control definitions and all Issue numbering information removed.
Bleeding Disorder See Change Notification No. 18 - 2007

Changes introduced with Release 04
Tamiflu® (oseltamivir) See Change Notification No. 30 - 2009
Relenza® (zanamivir) See Change Notification No. 31 - 2009

Changes introduced with Release 05
Acupuncture See Change Notification No. 33 - 2009
Complementary Therapy See Change Notification No. 35 - 2009

Changes introduced with Release 06
Body Piercing See Change Notification No. 02 - 2010
Endoscopy See Change Notification No. 03 - 2010
Inoculation Injury See Change Notification No. 04 - 2010

Changes introduced with Release 07
West Nile Virus (WNV) See Change Notification No. 09 - 2010

Changes introduced with Release 08
Infertility See Change Notification No. 08 - 2011
Sexually Transmitted Disease See Change Notification No. 09 - 2011

Changes introduced with Release 09
West Nile Virus See Change Notification No. 11 - 2011

Changes introduced with Release 10
Porphyria See Change Notification No. 20 - 2011

Changes introduced with Release 11
XMRV See Change Notification No. 25 - 2011
Hepatitis C See Change Notification No. 27 - 2011

Changes introduced with Release 12
West Nile Virus (WNV) See Change Notification No. 05 - 2012

Changes introduced with Release 13
Acne See Change Notification No. 15 - 2012
Psoriasis See Change Notification No. 17 - 2012
Toxoplasmosis See Change Notification No. 18 - 2012

Changes introduced with Release 13 Issue 02
Fertility treatment: entry replaced by link to infertility

Changes introduced with Release 14
West Nile Virus (WNV) See Change Notification No. 01 - 2013

Changes introduced with Release 15
Hepatitis B See Change Notification No. 08 - 2013
Hepatitis B Post Immunization See Change Notification No. 09 - 2013
Infection - Chronic See Change Notification No. 10 - 2013

Changes introduced with Release 16
Acupuncture See Change Notification No. 02 - 2014
Alitretinoin, Toctino, Acne and Dermatitis See Change Notification No. 03 - 2014
Body Piercing See Change Notification No. 04 - 2014
Central Nervous System Disease See Change Notification No. 05 - 2014
Hepatitis B - Post Immunization See Change Notification No. 06 - 2014
Hepatitis B See Change Notification No. 07 - 2014
Hepatitis of Unknown Origin See Change Notification No. 08 - 2014
Infection - Acute See Change Notification No. 09 - 2014
Kidney Disease See Change Notification No. 10 - 2014
Malignancy See Change Notification No. 11 - 2014
Mental Health Problems See Change Notification No. 12 - 2014
Sarcoidosis See Change Notification No. 13 - 2014
South American Trypanosomiasis Risk See Change Notification No. 14 - 2014
Paratyphoid and Typhoid See Change Notification No. 15 - 2014

Changes intorduced with Release 17
Haematological Disease See Change Notification No. 30 - 2014
SARS See Change Notification No.31 - 2014
Tissue Safety See Change Notification No.32 - 2014
Steroid Therapy See Change Notificiation No.33 - 2014
Homosexual and Bisexual Individuals See Change Notifcation No.35 - 2014

Go to the top of this page

 

 

Deceased Donors

This page lists all changes to TDSG-DD 203 after Release 02. This page constitutes Section 2 of Appendix 1 - Changes to the Donor Selection Guidelines.
The changes are listed with the most recent change at the top.

Changes introduced with Release 03
A change was made to the version control definitions and all Issue numbering information removed. No other changes where introduced.

Changes introduced with Release 04
Age See Change Notification No. 8 – 2009

Changes introduced with Release 05
Tamiflu® (oseltamivir) See Change Notification No. 28 - 2009
Relenza® (zanamivir) See Change Notification No. 29 - 2009

Changes introduced with Release 06
Acupuncture See Change Notification No. 33 - 2009
Complementary Therapy See Change Notification No. 35 - 2009

Changes introduced with Release 07
Body Piercing See Change Notification No. 02 - 2010
Inoculation Injury See Change Notification No. 04 - 2010

Changes introduced with Release 08
West Nile Virus (WNV) See Change Notification No. 09 - 2010

Changes introduced with Release 09
Immunization - Live See Change Notification No. 06 - 2011
BCG See Change Notification No. 07 - 2011
Infertility See Change Notification No. 08 - 2011
Sexually Transmitted Disease See Change Notification No. 09 - 2011

Changes introduced with Release 10
West Nile Virus See Change Notification No. 11 - 2011

Changes introduced with Release 11
Porphyria See Change Notification No. 20 - 2011
Immunosuppression See Change Notification No. 21 - 2011

Changes introduced with Release 12
XMRV See Change Notification No. 25 - 2011
Hepatitis C See Change Notification No. 27 - 2011

Changes introduced with Release 13
West Nile Virus (WNV) See Change Notification No. 05 - 2012

Changes introduced with Release 14
Acne See Change Notification No. 15 - 2012
Pregnancy See Change Notification No. 16 - 2012
Psoriasis See Change Notification No. 17 - 2012
Toxoplasmosis See Change Notification No. 18 - 2012

Changes introduced with Release 15
West Nile Virus (WNV) See Change Notification No. 01 - 2013

Changes introduced with Release 16
Hepatitis B See Change Notification No. 08 - 2013
Hepatitis B Post ImmunizationSee Change Notification No. 09 - 2013
Infection - ChronicSee Change Notification No. 10 - 2013

Changes introduced with Release 17
Acupuncture See Change Notification No. 02 - 2014
Alitretinoin, Toctino, Acne and Dermatitis See Change Notification No. 03 - 2014
Central Nervous System Disease See Change Notification No. 05 - 2014
Hepatitis of Unknown Origin See Change Notification No. 08 - 2014
Kidney Disease See Change Notification No. 10 - 2014
Malignancy See Change Notification No. 11 - 2014
Mental Health Problems See Change Notification No. 12 - 2014
Sarcoidosis See Change Notification No. 13 - 2014
South American Trypanosomiasis Risk See Change Notification No. 14 - 2014
Paratyphoid and Typhoid See Change Notification No. 15 - 2014

Changes introduced with Release 18
Haematological Disease See Change Notification No. 30 - 2014
SARS See Change Notification No. 31 - 2014
Tissues Safety See Change Notification No. 32 - 2014
Homosexual & Biosexual Individuals See Change Notification No. 36 - 2014
Sex Change See Change Notification No. 39 - 2014

Go to the top of this page

 

Live Donors

This page lists all changes to TDSG-LD 203 after Release 02. This page constitutes Section 2 of Appendix 1 - Changes to the Donor Selection Guidelines.
The changes are listed with the most recent change at the top.

Changes introduced with Release 03
A change was made to the version control definitions and all Issue numbering information removed.
Bleeding Disorder See Change Notification No. 18 - 2007

Changes introduced with Release 04
Tamiflu® (oseltamivir) See Change Notification No. 28 - 2009
Relenza® (zanamivir) See Change Notification No. 29 - 2009

Changes introduced with Release 05
Acupuncture See Change Notification No. 33 - 2009
Complementary Therapy See Change Notification No. 35 - 2009

Changes introduced with Release 06
Body Piercing See Change Notification No. 02 - 2010
Endoscopy See Change Notification No. 03 - 2010
Inoculation Injury See Change Notification No. 04 - 2010

Changes introduced with Release 07
West Nile Virus (WNV) See Change Notification No. 09 - 2010

Changes introduced with Release 08

Immunization - Live See Change Notification No. 06 - 2011
BCG See Change Notification No. 07 - 2011
Infertility See Change Notification No. 08 - 2011
Sexually Transmitted Disease See Change Notification No. 09 - 2011

Changes introduced with Release 09
West Nile Virus See Change Notification No. 11 - 2011

Changes introduced with Release 10
Malaria See Change Notification No. 14 - 2011

Changes introduced with Release 11
Porphyria See Change Notification No. 20 - 2011

Changes introduced with Release 12
XMRV See Change Notification No. 25 - 2011
Hepatitis C See Change Notification No. 27 - 2011

Changes introduced with Release 13
West Nile Virus (WNV) See Change Notification No. 05 - 2012

Changes introduced with Release 14
Acne See Change Notification No. 15 - 2012
Pregnancy See Change Notification No. 16 - 2012
Psoriasis See Change Notification No. 17 - 2012
Toxoplasmosis See Change Notification No. 18 - 2012

Changes introduced with Release 15
West Nile Virus (WNV) See Change Notification No. 01 - 2013

Changes introduced with Release 16
Hepatitis B See Change Notification No. 08 - 2013
Hepatitis B Post Immunization See Change Notification No. 09 - 2013
Infection - Chronic See Change Notification No. 10 - 2013

Changes introduced with Release 17
Acupuncture See Change Notification No. 02 - 2014
Alitretinoin, Toctino, Acne and Dermatitis See Change Notification No. 03 - 2014
Central Nervous System Disease See Change Notification No. 05 - 2014
Hepatitis of Unknown Origin See Change Notification No. 08 - 2014
Kidney Disease See Change Notification No. 10 - 2014
Malignancy See Change Notification No. 11 - 2014
Mental Health Problems See Change Notification No. 12 - 2014
Sarcoidosis See Change Notification No. 13 - 2014
South American Trypanosomiasis Risk See Change Notification No. 14 - 2014
Paratyphoid and Typhoid See Change Notification No. 15 - 2014

Changes introduced with Release 18
Haematological Disease See Change Notification No. 30 - 2014
SARS See Change Notification No. 31 - 2014
Tissues Safety See Change Notification No. 32 - 2014
Homosexual & Biosexual Individuals See Change Notification No. 37 - 2014
Sex Change See Change Notification No. 40 - 2014